Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemant Surgical Industries has filed its quarterly statement confirming there is no deviation or variation in the use of IPO proceeds for the quarter ended March 31, 2025. The company raised Rs. 2,484.00 lakhs through a fresh issue in its May 2023 IPO. Of the total, Rs. 2,421.16 lakhs has been utilized so far. Public issue expenses (Rs. 313.88 lakhs), working capital (Rs. 1,000.00 lakhs), and general corporate purpose (Rs. 418.86 lakhs) have been fully deployed. However, only Rs. 688.42 lakhs out of the Rs. 751.26 lakhs allocated for capital expenditure has been used, leaving Rs. 62.84 lakhs pending utilization. The filing was reviewed by the Audit Committee and approved by the Board on May 28, 2025.
This is a routine compliance filing with no deviation in objects or purposes, which is a positive governance signal for shareholders. Minor under-utilization of capex funds (about 8.4% unspent) suggests some delay in planned capital investment but is not a concern given the company has until the permitted deployment window. The stock is unlikely to react materially to this disclosure.